Matches in Wikidata for { <http://www.wikidata.org/entity/Q54901753> ?p ?o ?g. }
- Q54901753 description "2017 nî lūn-bûn" @default.
- Q54901753 description "2017年の論文" @default.
- Q54901753 description "2017年学术文章" @default.
- Q54901753 description "2017年学术文章" @default.
- Q54901753 description "2017年学术文章" @default.
- Q54901753 description "2017年学术文章" @default.
- Q54901753 description "2017年学术文章" @default.
- Q54901753 description "2017年學術文章" @default.
- Q54901753 description "2017年學術文章" @default.
- Q54901753 description "2017年學術文章" @default.
- Q54901753 description "2017年學術文章" @default.
- Q54901753 description "2017年學術文章" @default.
- Q54901753 description "2017年學術文章" @default.
- Q54901753 description "2017년 논문" @default.
- Q54901753 description "article científic" @default.
- Q54901753 description "article scientific" @default.
- Q54901753 description "article scientifique (publié 2017)" @default.
- Q54901753 description "articol științific" @default.
- Q54901753 description "articolo scientifico" @default.
- Q54901753 description "artigo científico (publicado na 2017)" @default.
- Q54901753 description "artigo científico (publicado na 2017)" @default.
- Q54901753 description "artigo científico" @default.
- Q54901753 description "artikull shkencor" @default.
- Q54901753 description "artikulong pang-agham" @default.
- Q54901753 description "artykuł naukowy" @default.
- Q54901753 description "artículo científico publicado en 2017" @default.
- Q54901753 description "artículu científicu" @default.
- Q54901753 description "bilimsel makale" @default.
- Q54901753 description "bài báo khoa học" @default.
- Q54901753 description "mokslinis straipsnis" @default.
- Q54901753 description "naučni članak" @default.
- Q54901753 description "scienca artikolo" @default.
- Q54901753 description "scientific article" @default.
- Q54901753 description "teaduslik artikkel" @default.
- Q54901753 description "tieteellinen artikkeli" @default.
- Q54901753 description "tudományos cikk" @default.
- Q54901753 description "vedecký článok" @default.
- Q54901753 description "vetenskaplig artikel" @default.
- Q54901753 description "videnskabelig artikel (udgivet 2017)" @default.
- Q54901753 description "vitenskapelig artikkel" @default.
- Q54901753 description "vitskapeleg artikkel" @default.
- Q54901753 description "vědecký článek" @default.
- Q54901753 description "wetenschappelijk artikel" @default.
- Q54901753 description "wissenschaftlicher Artikel" @default.
- Q54901753 description "επιστημονικό άρθρο" @default.
- Q54901753 description "мақолаи илмӣ" @default.
- Q54901753 description "мақолаи илмӣ" @default.
- Q54901753 description "наукова стаття, опублікована у квітні 2017" @default.
- Q54901753 description "научна статия" @default.
- Q54901753 description "научная статья" @default.
- Q54901753 description "научни чланак" @default.
- Q54901753 description "научни чланак" @default.
- Q54901753 description "գիտական հոդված" @default.
- Q54901753 description "מאמר מדעי" @default.
- Q54901753 description "سائنسی مضمون" @default.
- Q54901753 description "مقالة علمية" @default.
- Q54901753 description "مقالهٔ علمی" @default.
- Q54901753 description "২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q54901753 description "บทความทางวิทยาศาสตร์" @default.
- Q54901753 description "სამეცნიერო სტატია" @default.
- Q54901753 name "Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249." @default.
- Q54901753 name "Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249." @default.
- Q54901753 type Item @default.
- Q54901753 label "Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249." @default.
- Q54901753 label "Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249." @default.
- Q54901753 prefLabel "Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249." @default.
- Q54901753 prefLabel "Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249." @default.
- Q54901753 P1433 Q54901753-550C7258-2584-4F64-894E-7559F9BB0A4F @default.
- Q54901753 P1476 Q54901753-BFE4C9F6-E37F-4BB5-8012-CF4206F02C60 @default.
- Q54901753 P2093 Q54901753-0268A444-D09E-4AB6-B5E9-4ACB9F6ADAEA @default.
- Q54901753 P2093 Q54901753-0BBDB9E8-38C3-43F0-9FF9-24488A86AAFF @default.
- Q54901753 P2093 Q54901753-1FD1E553-8B7B-457B-AC95-52210CC6BB2E @default.
- Q54901753 P2093 Q54901753-2A378EB2-88CC-42FD-820B-581D5C56E2B2 @default.
- Q54901753 P2093 Q54901753-2CB245DC-9B1A-4400-9D4C-86B9E42A8788 @default.
- Q54901753 P2093 Q54901753-3695BD1A-F826-4796-AF68-0B5736E21EF5 @default.
- Q54901753 P2093 Q54901753-39B9A3AF-BBA7-4CBA-B50D-9B8D78AC8D4C @default.
- Q54901753 P2093 Q54901753-6DF6968D-769E-43A9-AFC3-03CC281AE1B5 @default.
- Q54901753 P2093 Q54901753-7248B459-B6CE-4635-AF62-1B2A3A9F713B @default.
- Q54901753 P2093 Q54901753-8174599A-1AD7-4BE6-8437-969378FEEC3F @default.
- Q54901753 P2093 Q54901753-AC2875DB-5954-45F6-80A4-21E9296895BF @default.
- Q54901753 P2093 Q54901753-F54A3285-78E2-49C9-A844-E54C7F101025 @default.
- Q54901753 P2093 Q54901753-FFA56389-596D-437D-ADCB-79F80E858D13 @default.
- Q54901753 P304 Q54901753-6C1E75E2-D4C4-441A-B73B-93A3DC347E66 @default.
- Q54901753 P31 Q54901753-55B9ED07-C02B-44C3-ABB7-D6040D04D4FD @default.
- Q54901753 P31 Q54901753-8ED9202C-2F42-4E2F-804D-5B8115C1EDC5 @default.
- Q54901753 P356 Q54901753-8BF81391-776B-4EB4-BB20-AA8C52163138 @default.
- Q54901753 P407 Q54901753-7C2AD24E-17EF-49EF-9128-628FE5E7F63E @default.
- Q54901753 P433 Q54901753-081D6A11-2E93-4385-B5A3-5CB54035186B @default.
- Q54901753 P478 Q54901753-75BDF659-2892-4BA1-9D7B-2BE1D0D33895 @default.
- Q54901753 P577 Q54901753-A011E6EB-5AC6-45E5-8F1B-F55FEA1967A9 @default.
- Q54901753 P698 Q54901753-69FB093E-775A-435A-A42B-F7650010E0A0 @default.
- Q54901753 P921 Q54901753-4EA6A73B-EB89-43EA-87B1-96225A96A1F2 @default.
- Q54901753 P921 Q54901753-7250C927-29D4-44FE-AABA-F7F452CBD47A @default.
- Q54901753 P921 Q54901753-BC4C6794-6DDB-4254-B0FC-278AAB3695AD @default.
- Q54901753 P932 Q54901753-47DD6F9A-D8B6-40BC-8930-28F4DB1A1596 @default.
- Q54901753 P356 DC17-ER06 @default.
- Q54901753 P698 28420698 @default.
- Q54901753 P1433 Q5270111 @default.
- Q54901753 P1476 "Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249." @default.
- Q54901753 P2093 "Andrew J Lewin" @default.